Register
Login:
Share:
Email Facebook Twitter


Angus Energy announces transformational joint venture with Cuadrilla & Lucas Energy
Aim-listed Mongolian explorer Petro Matad to drill four wells in 2018


Skinbiotherap. Share Price (SBTX)



Share Price Information for Skinbiotherap. (SBTX)


Share Price: 8.24Bid: 7.74Ask: 8.74Change: -0.26 (-3.06%)Faller - Skinbiotherap.
Spread: 1.00Spread as %: 12.92%Open: 8.50High: 8.50Low: 8.00Yesterday’s Close: 8.50

Skinbiotherapeutics Plc Ord 1P

Skinbiotherap. is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
8.24

Share Price SpacerBid
7.74

Share Price SpacerAsk
8.74

Share Price SpacerChange
-3.06%-0.26

Share Price SpacerVolume
141,836

Share Price SpacerOpen
8.50

Share Price SpacerHigh
8.50

Share Price SpacerLow
8.00

Share Price SpacerClose
8.50

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 118.71m £9.78m 10,000

52 Week High 17.75 52 Week High Date 7-APR-2017
52 Week Low 7.75 52 Week Low Date 7-FEB-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
7 77,454 49,382 -7.423 -1.11 0.00 0.00


London South East Users info for Skinbiotherap.




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

21-Feb-18
13:50:48
8.24
15,000
 
7.74
8.74
1,236
Trade Type:
Ordinary

21-Feb-18
13:11:14
8.10
49,382
Buy* 
7.50
8.50
4,000
Trade Type:
Ordinary

21-Feb-18
09:15:41
8.00
12,500
Sell* 
8.00
9.00
1,000.00
Trade Type:
Ordinary




View more Skinbiotherap. trades >>

Directors Deals for Skinbiotherap. (SBTX)
Trade DateActionNotifierPriceCurrencyAmountHolding
30-Mar-17Notification of Holding
Trade Notifier Information for SkinBioTherapeutics
Catherine Anne O'Neil held the position of CEO at SkinBioTherapeutics at the time of this trade.
 Catherine Anne O'Neil
005256989
30-Mar-17Notification of Holding
Trade Notifier Information for SkinBioTherapeutics
Martin Braddock Hunt held the position of Non-Executive Chairman at SkinBioTherapeutics at the time of this trade.
 Martin Braddock Hunt
00444444
30-Mar-17Notification of Holding
Trade Notifier Information for SkinBioTherapeutics
Douglas John Quinn held the position of CFO at SkinBioTherapeutics at the time of this trade.
 Douglas John Quinn
00444444
View more Skinbiotherap. directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Today 09:49missthepenny62Positive update8.00Strong Buy
Skinbiotherapeutics "generating interest from potential commercial partners". Already passed safety trials. Cash in bank. Low cost/risk process of upcoming cosmetic efficacy trial which if successful could lead to "billions". Market cap around £10m. "Industrial size scale-up" already underway.

The only reason I can think of for the slight dip after these results is that someone 'big' finally sees the value and has asked the MMs to load up on the cheap?… Read More
29 Jan '18PlayoffSundayRE: Very cheap to buy8.75No Opinion
This could be like N4P! Of course they need to announce human trials have started but no surprise to see good news soon.

The official SkinBio Twitter account mentioned last week presenting at investor evenings on the 20th Feb and 28th Feb.
29 Jan '18PlayoffSundayVery cheap to buy8.75No Opinion
9p on the ask. No news not helping but that's good for me to buy in!
5 Jan '18BigdollarRE: Good day to buy9.50No Opinion
General comment about the company providing regular updates, which is great.
5 Jan '18elricoRE: Good day to buy9.50No Opinion
what news slow?
5 Jan '18BigdollarWell done9.50No Opinion
To anyone who bought at yesterday's record low SP!

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Skinbiotherap. (SBTX) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.